| EMERGENT BIOSOLUTIONS |
| USA |
| Gesundheit |
| US29089Q1058 / A0LC2W |
| ER4 (Frankfurt) / EBS (NYSE) |
| FRA:ER4, ETR:ER4, ER4:GR, NYSE:EBS |
| - |
| https://www.emergentbioso.. |
|
Emergent BioSolutions Inc. is a global life sciences company that primarily focuses on the development, manufacturing, and distribution of a wide array of medical products. These products are designed..
>Volltext.. |
| 489.89 Mio. EUR |
| 849.51 Mio. EUR |
| 668.36 Mio. EUR |
| 182.83 Mio. EUR |
| 64.3 Mio. EUR |
| 1.2 EUR |
| 568.48 Mio. EUR |
| 211.12 Mio. EUR |
| 11.01 Mio. EUR |
| 1.83 |
| -33.49% |
| - |
| - |
| - |
| - |
| - |
| EMERGENT BIOSOLUTIONS, EMERGENT BIO |
| 27.02.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|